SARS-CoV-2 Mpro-IN-6

Modify Date: 2025-08-22 17:44:07

SARS-CoV-2 Mpro-IN-6 Structure
SARS-CoV-2 Mpro-IN-6 structure
Common Name SARS-CoV-2 Mpro-IN-6
CAS Number 2768834-48-4 Molecular Weight 446.78
Density N/A Boiling Point N/A
Molecular Formula C18H18Cl3N3O2S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of SARS-CoV-2 Mpro-IN-6


SARS-CoV-2 Mpro-IN-6 is a covalent, irreversible and selective SARS-CoV-2 Mpro inhibitor with an IC50 of 0.18 μM. SARS-CoV-2 Mpro-IN-6 does not inhibit human cathepsins B, F, K, and L, and caspase 3[1].

 Names

Name SARS-CoV-2 Mpro-IN-6

 SARS-CoV-2 Mpro-IN-6 Biological Activity

Description SARS-CoV-2 Mpro-IN-6 is a covalent, irreversible and selective SARS-CoV-2 Mpro inhibitor with an IC50 of 0.18 μM. SARS-CoV-2 Mpro-IN-6 does not inhibit human cathepsins B, F, K, and L, and caspase 3[1].
Related Catalog
Target

IC50: 0.18 μM (SARS-CoV-2 Mpro)[1]

In Vitro SARS-CoV-2 Mpro-IN-6 (GD-9) 对 SARS-CoV-2 显示出良好的抗病毒效力 (ECsub>50 = 2.64 μM)。SARS-CoV-2 Mpro-IN-6 在 Vero E6 细胞 中表现出一定的细胞毒性(CCsub>50 为 12.51 μM)[1]。
References

[1]. Shenghua Gao, et al. Discovery and Crystallographic Studies of Nonpeptidic Piperazine Derivatives as Covalent SARS-CoV-2 Main Protease Inhibitors. J Med Chem. 2022 Dec 22;65(24):16902-16917.  

 Chemical & Physical Properties

Molecular Formula C18H18Cl3N3O2S
Molecular Weight 446.78
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.